CPP-ZFN: A potential DNA-targeting anti-malarial drug

BACKGROUND: Multidrug-resistant Plasmodium is of major concern today. Effective vaccines or successful applications of RNAi-based strategies for the treatment of malaria are currently unavailable. An unexplored area in the field of malaria research is the development of DNA-targeting drugs that can...

Descripción completa

Detalles Bibliográficos
Autores principales: Nain, Vikrant, Sahi, Shakti, Verma, Anju
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949742/
https://www.ncbi.nlm.nih.gov/pubmed/20846404
http://dx.doi.org/10.1186/1475-2875-9-258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949742/
https://www.ncbi.nlm.nih.gov/pubmed/20846404
http://dx.doi.org/10.1186/1475-2875-9-258

Ejemplares similares